Ebola virus disease
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Persons who met all of the following criteria is enrolled in the study. 1. Among those who experienced one of the following events (A-D) of Ebola virus exposure, the Case Management Committee evaluates the appropriateness of the subject for this study. A Penetration of skin by sharps contaminated with blood or body fluids of an Ebola virus-infected patient (e.g. needle stick injury). B Contamination of mucous membrane or broken skin with blood or body fluids of an Ebola virus-infected patient. C Performing aerosol-producing procedure (e.g. cardiopulmonary resuscitation) on an Ebola virus-infected patient without use of appropriate personal protective equipment. D Prolonged (for hours) contact with an Ebola virus-infected patient in an enclosed space like an aircraft cabin without use of appropriate personal protective equipment. 2. Principally, male and female aged 20 years or older. However, even minors are allowed to participate in the study only when his/her doctor understands the significance of the post-exposure treatment provided in this study. 3. Persons aged 20 years or older who submitted informed consent. Proxy consent is acceptable in case the person is incompetent to consent to the contract. For those under 20 years old, written consent of both the person and his/her parent (or the replacement) is required for junior-high and high school students. For primary school children or younger, written consent of his/her parent (or the replacement) is required.
Exclusion criteria
Exclusion criteria: Person who conflicts any of the following criteria cannot be enrolled in the study. 1. Person who has a high fever 2. Person who was considered as inadequate for this study by the Case Management Committee.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence or absence of Ebola virus disease at the end of study or at discontinuation | — |
Countries
Japan
Contacts
National Center for Global Health and Medicine Division of Preparedness and Emerging Infections, Disease Control and Prevention Center